Page last updated: 2024-09-02

1-hydroxymethylmidazolam and exp3174

1-hydroxymethylmidazolam has been researched along with exp3174 in 1 studies

Compound Research Comparison

Studies
(1-hydroxymethylmidazolam)
Trials
(1-hydroxymethylmidazolam)
Recent Studies (post-2010)
(1-hydroxymethylmidazolam)
Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010) (exp3174)
16346492362943

Protein Interaction Comparison

ProteinTaxonomy1-hydroxymethylmidazolam (IC50)exp3174 (IC50)
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0013
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0027
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0036
Type-1 angiotensin II receptorHomo sapiens (human)0.002
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0075
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0075

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akamatsu, T; Chida, K; Inui, N; Karayama, M; Namiki, N; Tanaka, S; Uchida, S; Watanabe, H1

Other Studies

1 other study(ies) available for 1-hydroxymethylmidazolam and exp3174

ArticleYear
Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healthy Japanese volunteers, using the cocktail method.
    Clinical pharmacology and therapeutics, 2013, Volume: 94, Issue:6

    Topics: Adult; Antibiotics, Antitubercular; Asian People; Caffeine; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Imidazoles; Losartan; Male; Midazolam; Omeprazole; Rifampin; Tetrazoles; Theophylline; Time Factors; Withholding Treatment

2013